Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice
Open Access
- 1 July 2011
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 121 (7) , 2570-2582
Abstract
Vaccination using DCs pulsed with tumor lysates or specific tumor-associated peptides has so far yielded limited clinical success for cancer treatment, due mainly to the low immunogenicity of tumor-associated antigens. In this study, we have identified intratumoral virus-induced inflammation as a precondition for effective antitumor DC vaccination in mice. Administration of a tumor-targeted DC vaccine during ongoing virus-induced tumor inflammation, a regimen referred to as oncolysis-assisted DC vaccination (ODC), elicited potent antitumoral CD8+ T cell responses. This potent effect was not replicated by TLR activation outside the context of viral infection. ODC-elicited immune responses mediated marked tumor regression and successful eradication of preestablished lung colonies, an essential prerequisite for potentially treating metastatic cancers. Unexpectedly, depletion of Tregs during ODC did not enhance therapeutic efficacy; rather, it abrogated antitumor cytotoxicity. This phenomenon could be attributed to a compensatory induction of myeloid-derived suppressor cells in Treg-depleted and thus vigorously inflamed tumors, which prevented ODC-mediated immune responses. Consequently, Tregs are not only general suppressors of immune responses, but are essential for the therapeutic success of multimodal and temporally fine-adjusted vaccination strategies. Our results highlight tumor-targeting, replication-competent viruses as attractive tools for eliciting effective antitumor responses upon DC vaccination.Keywords
This publication has 49 references indexed in Scilit:
- Reprogrammed Foxp3+ Regulatory T Cells Provide Essential Help to Support Cross-presentation and CD8+ T Cell Priming in Naive MiceImmunity, 2010
- Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral ImmunityMolecular Therapy, 2010
- CD25 + Natural Regulatory T Cells Are Critical in Limiting Innate and Adaptive Immunity and Resolving Disease following Respiratory Syncytial Virus InfectionJournal of Virology, 2010
- Potentiating Cancer Immunotherapy Using an Oncolytic VirusMolecular Therapy, 2010
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationProceedings of the National Academy of Sciences, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Orchestrating the orchestrators: chemokines in control of T cell trafficNature Immunology, 2008
- Coordination of Early Protective Immunity to Viral Infection by Regulatory T CellsScience, 2008
- Suppression of Acute Anti-Friend Virus CD8+T-Cell Responses by Coinfection with Lactate Dehydrogenase-Elevating VirusJournal of Virology, 2008
- Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like diseaseJournal of Experimental Medicine, 2007